Article info

Download PDFPDF

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up
  1. Correspondence to:
 Professor J P Zajicek Peninsula Medical School
 Room N16, ITTC Building, Tamar Science Park, Plymouth, Devon PL6 8BX, UK; john.zajicekphnt.swest.nhs.uk
View Full Text

Citation

Zajicek JP, Sanders HP, Wright DE, et al
Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up

Publication history

  • Received April 25, 2005
  • Accepted July 2, 2005
  • Revised June 15, 2005
  • First published November 16, 2005.
Online issue publication 
November 16, 2005

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.